There are few reports on the decrease of PLT and ALB (before treatments) caused by CCA; however, the obstruction and cholestasis caused by CCA could lead to hepatocellular damage (Shin, Moon & Kim, 2023), which also has the possibility of influencing the levels of PLT and ALB. The gene discussed is ALB; the disease is cholestasis.